RCKT$2.541.00%0.025
After Hours: 2.51-0.03 -0.99%
Rocket Pharmaceuticals Inc (RCKT)
Date: 2026-11-04 16:00O: 2.60H: 2.66L: 2.48C: 2.61Vol: 1.637M
Rocket Pharmaceuticals Inc stock is traded at $2.54, with a volume of 415,888. It is up +1.00% in the last 24 hours and down -0.98% over the past month. Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Previous Close:
$2.51
Open:
$2.60
24h Volume:
415,888
Relative Volume:
0.24
Market Cap:
$278.28M
Revenue:
-
Net Income/Loss:
-$209.38M
P/E Ratio:
-
EPS:
-$1.88
Net Cash Flow:
-$179.81M
1W Performance:
-1.74%
1M Performance:
-0.98%
6M Performance:
-29.78%
1Y Performance:
-22.95%
1-Day Range:
$2.48$2.66
1-Week Range:
$2.37$2.67
52-Week Range:
$2.17$5.45
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Name
Rocket Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
646-440-9100Address
350 FIFTH AVENUE, NEW YORK, NY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
Rocket Pharmaceuticals Inc Stock (RCKT) Financials Data
Rocket Pharmaceuticals Inc Stock (RCKT) Insider Trading
- Militello JohnSep 15 '26Former Officer
- Transaction
- Proposed Sale
- Cost
- $3.30
- #Shares
- 6,897
- Value ($)
- 22,730
- #Shares Total
- 0
- Militello JohnSep 14 '26Former Officer
- Transaction
- Proposed Sale
- Cost
- $3.32
- #Shares
- 6,857
- Value ($)
- 22,731
- #Shares Total
- 0
- Wilson MartinSep 11 '26Officer
- Transaction
- Proposed Sale
- Cost
- $3.40
- #Shares
- 75,364
- Value ($)
- 256,486
- #Shares Total
- 0
- Militello JohnSep 11 '26Former Officer
- Transaction
- Proposed Sale
- Cost
- $3.40
- #Shares
- 8,923
- Value ($)
- 30,368
- #Shares Total
- 0
- Wilson MartinSep 11 '26General Counsel
- Transaction
- Sale
- Cost
- $3.40
- #Shares
- 75,364
- Value ($)
- 256,464
- #Shares Total
- 598,489
- Militello JohnAug 18 '26Former Officer
- Transaction
- Proposed Sale
- Cost
- $3.38
- #Shares
- 1,252
- Value ($)
- 4,234
- #Shares Total
- 0
- Wilson MartinAug 18 '26General Counsel
- Transaction
- Sale
- Cost
- $3.38
- #Shares
- 631
- Value ($)
- 2,133
- #Shares Total
- 673,853
- Shah GauravAug 18 '26CEO
- Transaction
- Sale
- Cost
- $3.38
- #Shares
- 2,293
- Value ($)
- 7,753
- #Shares Total
- 1,056,594
- Shah GauravAug 18 '26Officer
- Transaction
- Proposed Sale
- Cost
- $3.38
- #Shares
- 2,293
- Value ($)
- 7,754
- #Shares Total
- 0
- Wilson MartinAug 18 '26Officer
- Transaction
- Proposed Sale
- Cost
- $3.38
- #Shares
- 631
- Value ($)
- 2,134
- #Shares Total
- 0
